Immunology &
Transplant Medicines

Immunology & Transplant Medicine Supply for Hospitals & International Buyers

Organ transplantation depends on the uninterrupted supply of immunosuppressant medicines from the moment of transplant surgery and throughout the patient's lifetime. Any gap in supply can trigger acute rejection, lead to graft loss and require costly and high-risk re-transplantation or return to dialysis. The consequences of even a brief interruption to tacrolimus or ciclosporin therapy can be irreversible, which means transplant centres treat their immunosuppressant supply chains with the same clinical urgency as the surgical programme itself. Euro Biom works directly with transplant hospital procurement teams, specialist pharmacy departments and international distributors to ensure these medicines are available at all times, including in urgent and shortage scenarios.

Tacrolimus is the cornerstone immunosuppressant for kidney, liver, heart and lung transplantation. It is available in immediate-release capsules (Prograf and generics) and the modified-release formulation Advagraf, which offers once-daily dosing and improved adherence. A critical clinical consideration for international buyers is that tacrolimus products are not interchangeable without close therapeutic drug monitoring: the pharmacokinetic profiles of different brands and formulations differ, and switching requires clinical supervision. Many transplant centres therefore specify brand continuity rather than generic substitution. Euro Biom regularly supplies specific tacrolimus brands for GCC and African transplant programmes where the patient was stabilised on a UK-branded product and continuity is essential for safety.

Ciclosporin remains in use for renal, hepatic and cardiac transplant maintenance, and is also used in dermatology, rheumatology and ophthalmology. Neoral (ciclosporin microemulsion) is the formulation most commonly specified in transplant protocols, and like tacrolimus it is not generically interchangeable without monitoring. We can source Neoral and ciclosporin eye drops (Ikervis, Restasis) for specialist ophthalmic indications. Azathioprine, an older antimetabolite still used in combination regimens and as a steroid-sparing agent in autoimmune conditions, is also available across standard strengths.

Mycophenolate mofetil (CellCept and generics) is used alongside calcineurin inhibitors in most transplant maintenance protocols to reduce rejection rates. Dosing in transplant patients is weight-based and adjusted by tolerability, and some protocols use enteric-coated mycophenolate sodium (Myfortic) in patients who experience gastrointestinal side effects with the mofetil form. Both formulations are available through our supply network. mTOR inhibitors sirolimus (rapamycin) and everolimus are used in calcineurin-inhibitor-sparing regimens and in selected cardiac and liver transplant protocols, and are regularly requested by international buyers where local market supply is unreliable.

Corticosteroids in Transplant and Autoimmune Protocols

Corticosteroids are foundational in both transplant and autoimmune protocols. High-dose intravenous methylprednisolone (Solu-Medrol) is used for acute rejection episodes and autoimmune flares. Oral prednisolone at various doses forms part of maintenance regimens in transplant, inflammatory bowel disease, vasculitis and connective tissue diseases. Hydrocortisone tablets are used for maintenance therapy in steroid-dependent patients. Hydrocortisone injection is subject to UK export restrictions and falls outside Euro Biom's supply scope. UK availability of oral hydrocortisone formulations is confirmed against each enquiry.

GCC transplant programmes have expanded significantly over the past decade, with kidney and liver transplantation now well-established in Saudi Arabia, the UAE, Kuwait and Qatar. These programmes typically use UK and European sourced medicines as their reference standard, and their procurement teams often look to UK licensed wholesalers as their primary supply partners. Euro Biom holds a MHRA Wholesale Dealer Authorisation and operates under GDP principles, which means our documentation and our GDP-compliant contract site's storage and cold-chain processes meet the standards required for import licensing in GCC health authority frameworks. Our named-patient import team has extensive experience managing the clinical, regulatory and logistical requirements of transplant medicine supply for international buyers.